India Considers Blue Strips For Antimicrobials To Combat Drug Misuse
New Delhi: As India intensifies its battle against antimicrobial-resistant superbugs, the drug regulator is considering a proposal to change the colour of all antimicrobial drug strips to blue. This initiative aims…
Lumpy Skin Disease Vaccine Will Be Launched Soon, Says Govt
NEW DELHI: The Central Government said that it will release vaccination for Lumpy Skin Disease (LSD) on September 18. It is a viral disease that affects cattle and buffalo, and…
Indian Patent Office To Hear Objections On Gilead’s HIV Drug Patent Claims
Mumbai: The Indian Patent Office is set to hear objections against patent claims filed by US-based pharmaceutical giant Gilead Sciences on HIV prevention drug “Lenacapavir”. Sankalp Rehabilitation Trust, a civil society…
Delhi’s groundwater has high levels of salt that are dangerous for kidneys
A recent report by the Central Ground Water Authority (CGWA) has highlighted concerning levels of salinity in Delhi’s groundwater. According to the data, more than one in four water samples…
One-Third Of India’s 30 Lakh Sepsis Deaths Linked To Antimicrobial Resistance
New Delhi: In 2019, between 3 and 10.4 lakh people in India died due to bacterial antimicrobial resistance (AMR), a condition in which pathogenic bacteria no longer respond to antibiotics,…
DCC Recommends Making Sugam Portal Database Of All Products With Brand Names
New Delhi: The Drugs Consultative Committee (DCC), the advisory committee that advises the Central and state governments on matters that require uniform implementation of drug laws across the country, has recommended…
ICMR Signs MoAs To Advance First-In-Human Clinical Trials For Four Promising Molecules
New Delhi: In a significant stride towards strengthening India’s clinical research ecosystem, the Indian Council of Medical Research (ICMR) has formalized Memorandum of Agreements (MoAs) with multiple sponsors under its Network…
Indian Immunologicals And ICMR Sign MoU For Zika Vaccine
Hyderabad: Vaccine maker Indian Immunologicals (IIL) and Indian Council of Medical Research (ICMR) have signed a memorandum of agreement (MoA) for clinical development of the country’s first codon de-optimised live attenuated…
NITI Aayog’s Expert Group Recommends CDSCO To Be Made An Independent Regulatory Authority
New Delhi: An expert group constituted by NITI Aayog to prepare a framework for action for emergency response and preparedness to address future pandemic, has recommended making the Central Drugs…
FDI Equity Inflow Into Pharma Sector Grows To $236 Million In Q1FY25
New Delhi: The Foreign Direct Investment (FDI) equity inflow into the pharmaceutical sector has reported multifold growth during the first quarter of the current fiscal year, after registering a 48 per…
